![Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update](https://www.frontiersin.org/files/Articles/1022530/fgstr-01-1022530-HTML-r1/image_m/fgstr-01-1022530-g001.jpg)
Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
![Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis - ScienceDirect Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356520313768-gr1.jpg)
Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis - ScienceDirect
Abstract for DDW and ECCO 2019 (ECCO submission deadline: Nov 22, 2018) Maintenance of efficacy following tofacitinib dose reduc
![UArctic - University of the Arctic - International Congress on Circumpolar Health: Registration and Call for Abstracts open UArctic - University of the Arctic - International Congress on Circumpolar Health: Registration and Call for Abstracts open](https://ua.vps03.fwstatic.download/media/1598395/icch17.jpg?anchor=center&mode=crop&width=1080&height=675&slimmage=true&bgcolor=fff&format=jpg&rnd=132990744904770000)
UArctic - University of the Arctic - International Congress on Circumpolar Health: Registration and Call for Abstracts open
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
![Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-021-01883-6/MediaObjects/12876_2021_1883_Fig1_HTML.png)
Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text
![PDF) P140 Use of vedolizumab in a transplanted liver patient: a case report of the first experience in a liver transplant referral center in Argentina PDF) P140 Use of vedolizumab in a transplanted liver patient: a case report of the first experience in a liver transplant referral center in Argentina](https://i1.rgstatic.net/publication/313467483_P140_Use_of_vedolizumab_in_a_transplanted_liver_patient_a_case_report_of_the_first_experience_in_a_liver_transplant_referral_center_in_Argentina/links/5d6acc394585150886045824/largepreview.png)
PDF) P140 Use of vedolizumab in a transplanted liver patient: a case report of the first experience in a liver transplant referral center in Argentina
![PDF) Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's Disease PDF) Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's Disease](https://i1.rgstatic.net/publication/330712762_Assessment_of_Bowel_Inflammation_and_Strictures_by_Magnetic_Resonance_Enterography_in_Long-term_Crohn's_Disease/links/5c50586292851c22a398a626/largepreview.png)
PDF) Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's Disease
![PDF) P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases PDF) P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases](https://i1.rgstatic.net/publication/330643099_P251_RAID_Dx_the_first_test_based_on_faecal_microbiota_to_differentiate_irritable_bowel_syndrome_from_inflammatory_bowel_diseases/links/5d2c7ecb92851cf44085591e/largepreview.png)